ABBV vs UTHR
As of Sep 20, 2026, AbbVie (ABBV) scores 7.8/10 and UNITED THERAPEUTICS (UTHR) 4.8/10 on AlphaStocks' five-model composite, so ABBV scores higher. ABBV trades 102% above its model fair value.
ABBV
AbbVie Inc.
7.8
Strong Buy
$263.86
UTHR
UNITED THERAPEUTICS Corp
4.8
Weak
$494.96
ABBV vs UTHR: Which is the Better Investment?
AbbVie Inc. (ABBV) scores 7.8/10 while UNITED THERAPEUTICS Corp (UTHR) scores 4.8/10 on AlphaStocks' composite model. AbbVie Inc. has the higher composite rating of Strong Buy. On a P/E basis, UNITED THERAPEUTICS Corp trades at 17.8x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | ABBV | UTHR |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 7.8/10▲ | 4.8/10 |
| Rating | Strong Buy▲ | Weak |
| Price | $263.86 | $494.96 |
| P/E Ratio | 110.7 | 17.8▲ |
| ROE | -143.0% | 15.9%▲ |
| Market Cap | $468B | $23B |
| Fair Value | $130.53 | — |
| Dividend Yield | 2.7% | — |
| Sector Rank | #2 of 168▲ | #121 of 168 |
| Model Verdicts | ||
| Piotroski | Strong | Strong |
| Buffett | Strong▲ | Attractive |
| Graham | Neutral | Neutral |
| Lynch | Neutral | Strong▲ |
| Greenblatt | Neutral | Attractive▲ |
Related comparisons
ABBV vs UTHR: Which Stock Scores Higher?
AbbVie Inc. (ABBV) and UNITED THERAPEUTICS Corp (UTHR) are both in the Health Care sector. ABBV currently leads with a composite score of 7.8/10 (Strong Buy) compared to UTHR's 4.8/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer